Hirofumi Kai
7PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 17, 2025
Efficacy of Nrf2 activation in a proteinuric Alport syndrome mouse model.Shota Kaseda, Jun Horizono, Yuya Sannomiya
|Apr 24, 2024
Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome.Yuimi Koyama, Mary Ann Suico, Aimi Owaki
|May 05, 2023
CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion.Jun Kuwazuru, Mary Ann Suico, Kohei Omachi
|Jun 20, 2022
Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model.Shota Kaseda, Yuya Sannomiya, Jun Horizono
|Nov 20, 2020
Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome.Kandai Nozu, Yutaka Takaoka, Hirofumi Kai
|Jun 23, 2020
A novel condition of mild electrical stimulation exerts immunosuppression via hydrogen peroxide production that controls multiple signaling pathway.Mariam Piruzyan, Ihori Shitanda, Yuichiro Shimauchi
Pageof 2
Frequent Collaborators
3 joint publications
Mary Ann Suico
2 joint publications
Jun Kuwazuru
1 joint publications
Kandai Nozu
1 joint publications
Yutaka Takaoka
1 joint publications
Minoru Takasato
1 joint publications
Kensuke Yabuuchi
1 joint publications
Tomohiko Yamamura
1 joint publications
Tomoko Horinouchi
1 joint publications
Nana Sakakibara
1 joint publications
Takeshi Ninchoji
